[3-chloro-4-[2-[2-(2-methylpropyl)-4-pyridinyl]-1H-imidazol-5-yl]phenyl]-piperidin-1-ylmethanone
C24H27ClN4O — CID 134263527
Data last refreshed: (MolForge compound catalog, from PubChem)
About [3-chloro-4-[2-[2-(2-methylpropyl)-4-pyridinyl]-1H-imidazol-5-yl]phenyl]-piperidin-1-ylmethanone
[3-chloro-4-[2-[2-(2-methylpropyl)-4-pyridinyl]-1H-imidazol-5-yl]phenyl]-piperidin-1-ylmethanone (PubChem CID 134263527) has the molecular formula C24H27ClN4O and a molecular weight of 422.96 g/mol. Its IUPAC name is [3-chloro-4-[2-[2-(2-methylpropyl)-4-pyridinyl]-1H-imidazol-5-yl]phenyl]-piperidin-1-ylmethanone.
Molecular Properties
| Compound Name | [3-chloro-4-[2-[2-(2-methylpropyl)-4-pyridinyl]-1H-imidazol-5-yl]phenyl]-piperidin-1-ylmethanone |
|---|---|
| PubChem CID | 134263527 |
| Molecular Formula | C24H27ClN4O |
| Molecular Weight | 422.96 g/mol |
| Exact Mass | 422.19 |
| IUPAC Name | [3-chloro-4-[2-[2-(2-methylpropyl)-4-pyridinyl]-1H-imidazol-5-yl]phenyl]-piperidin-1-ylmethanone |
| SMILES | CC(C)Cc1cc(-c2ncc(-c3ccc(C(=O)N4CCCCC4)cc3Cl)[nH]2)ccn1 |
| InChI | InChI=1S/C24H27ClN4O/c1-16(2)12-19-13-17(8-9-26-19)23-27-15-22(28-23)20-7-6-18(14-21(20)25)24(30)29-10-4-3-5-11-29/h6-9,13-16H,3-5,10-12H2,1-2H3,(H,27,28) |
| InChIKey | SVQMNIXHOPSUDA-UHFFFAOYSA-N |
| XLogP | 5.62 |
| TPSA | 61.88 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 422.96 |
| LogP ≤ 5 | 5.62 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 3 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 134263527 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.